KARACHI: The Searle Company Limited has concluded an agreement with China’s Livzon Mapharm Inc. for the manufacturing of novel coronavirus vaccine (V-01) in Pakistan. “The Searle Company has concluded an exclusive licensing and supply agreement with Livzon Mapharm Inc. for the recombinant novel coronavirus vaccine (V-01). The licensing agreement also covers the manufacturing transition of…